Annual total expenses:
$324.94M+$24.23M(+8.06%)Summary
- As of today (May 30, 2025), ARQT annual total expenses is $324.94 million, with the most recent change of +$24.23 million (+8.06%) on December 31, 2024.
- During the last 3 years, ARQT annual total expenses has risen by +$118.41 million (+57.33%).
- ARQT annual total expenses is now at all-time high.
Performance
ARQT Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$90.38M+$11.38M(+14.41%)Summary
- As of today (May 30, 2025), ARQT quarterly total expenses is $90.38 million, with the most recent change of +$11.38 million (+14.41%) on March 31, 2025.
- Over the past year, ARQT quarterly total expenses has increased by +$9.18 million (+11.31%).
- ARQT quarterly total expenses is now -14.31% below its all-time high of $105.47 million, reached on September 30, 2022.
Performance
ARQT Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ARQT Total expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +8.1% | +11.3% |
3 y3 years | +57.3% | +44.3% |
5 y5 years | +653.4% | +215.4% |
ARQT Total expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +57.3% | -14.3% | +44.3% |
5 y | 5-year | at high | +653.4% | -14.3% | +215.4% |
alltime | all time | at high | +7813.8% | -14.3% | +1418.1% |
ARQT Total expenses History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $90.38M(+14.4%) |
Dec 2024 | $324.94M(+8.1%) | $78.99M(-5.8%) |
Sep 2024 | - | $83.82M(+3.6%) |
Jun 2024 | - | $80.94M(-0.3%) |
Mar 2024 | - | $81.19M(+8.7%) |
Dec 2023 | $300.71M(-1.5%) | $74.69M(-0.4%) |
Sep 2023 | - | $75.01M(+4.3%) |
Jun 2023 | - | $71.95M(-9.0%) |
Mar 2023 | - | $79.05M(+10.7%) |
Dec 2022 | $305.31M(+47.8%) | $71.39M(-32.3%) |
Sep 2022 | - | $105.47M(+60.2%) |
Jun 2022 | - | $65.83M(+5.1%) |
Mar 2022 | - | $62.63M(-12.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $206.53M(+51.1%) | $71.29M(+24.9%) |
Sep 2021 | - | $57.08M(+35.6%) |
Jun 2021 | - | $42.08M(+16.6%) |
Mar 2021 | - | $36.09M(+5.9%) |
Dec 2020 | $136.65M(+216.8%) | $34.06M(-11.1%) |
Sep 2020 | - | $38.30M(+7.5%) |
Jun 2020 | - | $35.63M(+24.3%) |
Mar 2020 | - | $28.65M(+120.5%) |
Dec 2019 | $43.13M(+118.6%) | $12.99M(-11.3%) |
Sep 2019 | - | $14.65M(+71.6%) |
Jun 2019 | - | $8.54M(+22.8%) |
Mar 2019 | - | $6.95M(+16.8%) |
Dec 2018 | $19.73M(+380.6%) | $5.95M |
Dec 2017 | $4.11M | - |
FAQ
- What is Arcutis Biotherapeutics annual total expenses?
- What is the all time high annual total expenses for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual total expenses year-on-year change?
- What is Arcutis Biotherapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly total expenses year-on-year change?
What is Arcutis Biotherapeutics annual total expenses?
The current annual total expenses of ARQT is $324.94M
What is the all time high annual total expenses for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual total expenses is $324.94M
What is Arcutis Biotherapeutics annual total expenses year-on-year change?
Over the past year, ARQT annual total expenses has changed by +$24.23M (+8.06%)
What is Arcutis Biotherapeutics quarterly total expenses?
The current quarterly total expenses of ARQT is $90.38M
What is the all time high quarterly total expenses for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly total expenses is $105.47M
What is Arcutis Biotherapeutics quarterly total expenses year-on-year change?
Over the past year, ARQT quarterly total expenses has changed by +$9.18M (+11.31%)